Food and Drug Administration Commissioner Marty Makary said his agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the US and other ...

The Department of Health and Human Services said it will reclassify those programs as federal public benefits, restricting ...